Global Novel Drug Delivery Systems Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Novel Drug Delivery Systems market size will reach 28,070 Million USD in 2025 and is projected to reach 31,413 Million USD by 2032, with a CAGR of 1.62% (2025-2032). Notably, the China Novel Drug Delivery Systems market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Novel drug delivery systems (NDDS) refer to innovative techniques or approaches used to deliver pharmaceutical substances to the body in a targeted and controlled manner. These systems aim to improve the therapeutic efficacy, safety, and convenience of drug administration by overcoming the limitations associated with conventional drug delivery methods. NDDS can include various technologies and formulations such as nanoparticles, liposomes, microparticles, implants, patches, inhalers, and transdermal systems. They often employ specialized carriers or vehicles to encapsulate and protect drugs, enabling controlled release, site-specific targeting, and enhanced drug stability. These advanced delivery systems offer advantages like improved drug bioavailability, reduced side effects, prolonged drug action, and enhanced patient compliance. NDDS play a crucial role in personalized medicine, precision therapy, and the development of therapeutic approaches for complex diseases. By exploring innovative ways to deliver drugs, NDDS contributes to advancements in therapeutic outcomes and patient care.
The major global suppliers of Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch & Lomb, Johnson & Johnson, Samyang Biopharmaceuticals, TOLMAR, Astellas, AbbVie, AMAG Pharmaceuticals, AstraZeneca, Dr Reddy, Aspen, Acrotech Biopharma, TWi Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Novel Drug Delivery Systems. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Novel Drug Delivery Systems market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Novel Drug Delivery Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Novel Drug Delivery Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Novel Drug Delivery Systems Include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch & Lomb
Johnson & Johnson
Samyang Biopharmaceuticals
TOLMAR
Astellas
AbbVie
AMAG Pharmaceuticals
AstraZeneca
Dr Reddy
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Novel Drug Delivery Systems Product Segment Include:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Novel Drug Delivery Systems Product Application Include:
Hospitals & Clinic
Cancer Treatment Centers
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Novel Drug Delivery Systems Industry PESTEL Analysis
Chapter 3: Global Novel Drug Delivery Systems Industry Porter's Five Forces Analysis
Chapter 4: Global Novel Drug Delivery Systems Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Novel Drug Delivery Systems Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Novel Drug Delivery Systems Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Novel Drug Delivery Systems Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Novel Drug Delivery Systems market size will reach 28,070 Million USD in 2025 and is projected to reach 31,413 Million USD by 2032, with a CAGR of 1.62% (2025-2032). Notably, the China Novel Drug Delivery Systems market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Novel drug delivery systems (NDDS) refer to innovative techniques or approaches used to deliver pharmaceutical substances to the body in a targeted and controlled manner. These systems aim to improve the therapeutic efficacy, safety, and convenience of drug administration by overcoming the limitations associated with conventional drug delivery methods. NDDS can include various technologies and formulations such as nanoparticles, liposomes, microparticles, implants, patches, inhalers, and transdermal systems. They often employ specialized carriers or vehicles to encapsulate and protect drugs, enabling controlled release, site-specific targeting, and enhanced drug stability. These advanced delivery systems offer advantages like improved drug bioavailability, reduced side effects, prolonged drug action, and enhanced patient compliance. NDDS play a crucial role in personalized medicine, precision therapy, and the development of therapeutic approaches for complex diseases. By exploring innovative ways to deliver drugs, NDDS contributes to advancements in therapeutic outcomes and patient care.
The major global suppliers of Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch & Lomb, Johnson & Johnson, Samyang Biopharmaceuticals, TOLMAR, Astellas, AbbVie, AMAG Pharmaceuticals, AstraZeneca, Dr Reddy, Aspen, Acrotech Biopharma, TWi Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Novel Drug Delivery Systems. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Novel Drug Delivery Systems market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Novel Drug Delivery Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Novel Drug Delivery Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Novel Drug Delivery Systems Include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch & Lomb
Johnson & Johnson
Samyang Biopharmaceuticals
TOLMAR
Astellas
AbbVie
AMAG Pharmaceuticals
AstraZeneca
Dr Reddy
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Novel Drug Delivery Systems Product Segment Include:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Novel Drug Delivery Systems Product Application Include:
Hospitals & Clinic
Cancer Treatment Centers
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Novel Drug Delivery Systems Industry PESTEL Analysis
Chapter 3: Global Novel Drug Delivery Systems Industry Porter's Five Forces Analysis
Chapter 4: Global Novel Drug Delivery Systems Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Novel Drug Delivery Systems Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Novel Drug Delivery Systems Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Novel Drug Delivery Systems Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Novel Drug Delivery Systems Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Novel Drug Delivery Systems Product by Type
- 1.2.1 Liposomes
- 1.2.2 PEGylated Proteins & Polypeptides
- 1.2.3 Polymer Nanoparticle
- 1.2.4 Protein–drug Conjugates
- 1.2.5 Others
- 1.3 Novel Drug Delivery Systems Product by Application
- 1.3.1 Hospitals & Clinic
- 1.3.2 Cancer Treatment Centers
- 1.3.3 Others
- 1.4 Global Novel Drug Delivery Systems Market Size Analysis (2020-2032)
- 1.5 Novel Drug Delivery Systems Market Development Status and Trends
- 1.5.1 Novel Drug Delivery Systems Industry Development Status Analysis
- 1.5.2 Novel Drug Delivery Systems Industry Development Trends Analysis
- 2 Novel Drug Delivery Systems Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Novel Drug Delivery Systems Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Novel Drug Delivery Systems Market Analysis by Country
- 4.1 Global Novel Drug Delivery Systems Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Novel Drug Delivery Systems Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Novel Drug Delivery Systems Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.5 China Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.6 France Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.14 India Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Novel Drug Delivery Systems Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Novel Drug Delivery Systems Market Revenue by Key Suppliers (2021-2025)
- 5.2 Novel Drug Delivery Systems Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Novel Drug Delivery Systems Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Novel Drug Delivery Systems Market Analysis by Type
- 6.1 Global Novel Drug Delivery Systems Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Novel Drug Delivery Systems Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Amgen
- 7.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Amgen Novel Drug Delivery Systems Product Portfolio
- 7.1.3 Amgen Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Teva
- 7.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Teva Novel Drug Delivery Systems Product Portfolio
- 7.2.3 Teva Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Roche
- 7.3.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Roche Novel Drug Delivery Systems Product Portfolio
- 7.3.3 Roche Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 UCB (Union Chimique Belge)
- 7.4.1 UCB (Union Chimique Belge) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Portfolio
- 7.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Celgene
- 7.5.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Celgene Novel Drug Delivery Systems Product Portfolio
- 7.5.3 Celgene Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Merck
- 7.6.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Merck Novel Drug Delivery Systems Product Portfolio
- 7.6.3 Merck Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Gilead Sciences
- 7.7.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Gilead Sciences Novel Drug Delivery Systems Product Portfolio
- 7.7.3 Gilead Sciences Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Sanofi
- 7.8.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Sanofi Novel Drug Delivery Systems Product Portfolio
- 7.8.3 Sanofi Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Pfizer
- 7.9.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Pfizer Novel Drug Delivery Systems Product Portfolio
- 7.9.3 Pfizer Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Takeda
- 7.10.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Takeda Novel Drug Delivery Systems Product Portfolio
- 7.10.3 Takeda Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Bausch & Lomb
- 7.11.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Bausch & Lomb Novel Drug Delivery Systems Product Portfolio
- 7.11.3 Bausch & Lomb Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Johnson & Johnson
- 7.12.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Johnson & Johnson Novel Drug Delivery Systems Product Portfolio
- 7.12.3 Johnson & Johnson Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Samyang Biopharmaceuticals
- 7.13.1 Samyang Biopharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 7.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 TOLMAR
- 7.14.1 TOLMAR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 TOLMAR Novel Drug Delivery Systems Product Portfolio
- 7.14.3 TOLMAR Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Astellas
- 7.15.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Astellas Novel Drug Delivery Systems Product Portfolio
- 7.15.3 Astellas Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 AbbVie
- 7.16.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 AbbVie Novel Drug Delivery Systems Product Portfolio
- 7.16.3 AbbVie Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 AMAG Pharmaceuticals
- 7.17.1 AMAG Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 7.17.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.18 AstraZeneca
- 7.18.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 AstraZeneca Novel Drug Delivery Systems Product Portfolio
- 7.18.3 AstraZeneca Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.19 Dr Reddy
- 7.19.1 Dr Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Dr Reddy Novel Drug Delivery Systems Product Portfolio
- 7.19.3 Dr Reddy Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.20 Aspen
- 7.20.1 Aspen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.20.2 Aspen Novel Drug Delivery Systems Product Portfolio
- 7.20.3 Aspen Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.21 Acrotech Biopharma
- 7.21.1 Acrotech Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Portfolio
- 7.21.3 Acrotech Biopharma Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.22 TWi Pharmaceuticals
- 7.22.1 TWi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 7.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Novel Drug Delivery Systems Industry Chain Analysis
- 8.2 Novel Drug Delivery Systems Product Downstream Application Analysis
- 8.2.1 Global Novel Drug Delivery Systems Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Novel Drug Delivery Systems Revenue and Forecast by Application (2020-2032)
- 8.3 Novel Drug Delivery Systems Typical Downstream Customers
- 8.4 Novel Drug Delivery Systems Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
